CAS 79836-56-9

trans-(±)-4-(4-BroMophenyl)-1,2,3,4- tetrahydro-N-Methyl-1-naphthalenaMine Hydrochloride

Description:

Trans-(±)-4-(4-Bromophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine hydrochloride, with the CAS number 79836-56-9, is a chemical compound characterized by its complex structure, which includes a naphthalene moiety and a tetrahydro derivative. This compound typically exhibits properties associated with amines, such as basicity and the ability to form salts, particularly in its hydrochloride form, which enhances its solubility in water. The presence of the bromophenyl group may impart specific electronic and steric effects, influencing its reactivity and potential biological activity. As a tetrahydro derivative, it is likely to be less rigid than its fully aromatic counterparts, allowing for conformational flexibility. This compound may be of interest in medicinal chemistry, particularly in the development of pharmaceuticals, due to its structural features that could interact with biological targets. Safety and handling precautions should be observed, as with all chemical substances, particularly those with halogenated groups, which can pose environmental and health risks.

Formula: C₁₇H₁₉BrClN

Synonyms:

• tetrahydro-N-Methyl-1-naphthalenaMine Hydrochloride
• CP-53631
• 1-naphthalenaMine Hydrochloride
• (1R,4S)-rel-4-(4-BroMophenyl)-1,2,3,4-tetrahydro-N-Methyl-1-naphthalenaMine Hydrochloride
• trans-(±)-4-(4-BroMophenyl)-1,2,3,4-
• trans-4-(4-BroMophenyl)-1,2,3,4-tetrahydro-N-Methyl-

CP-53631

CAS: 79836-56-9

Formula: C₁₇H₁₈BrN·HCl

Molecular weight: 352.70

Ref: 7W-GL3270

CP-53631

CAS: 79836-56-9

CP-53631 is a proton pump inhibitor (PPI) that blocks the production of stomach acid by inhibiting the activity of the H+/K+ ATPase enzyme. It is metabolized by cytochrome P450 enzymes CYP2C19 and CYP3A4, which may affect its efficacy when taken with other drugs that are metabolized by these enzymes. CP-53631 has been shown to inhibit serotonin reuptake in rats, which may lead to increased serotonin levels in humans. This drug also inhibits gastric acid secretion and has been shown to be more effective than esomeprazole for treating acid reflux disease. Monitoring serum concentrations of CP-53631 is recommended due to the potential for interactions with drugs such as proton pump inhibitors, clopidogrel, warfarin, and phenytoin.

Formula: C₁₇H₁₉BrClN

Purity: Min. 95%

Molecular weight: 352.7 g/mol

Ref: 3D-EDA83656

CP-53631

CAS: 79836-56-9

CP-53631 is a selective serotonin reuptake inhibitor (SSRI)

Formula: C₁₇H₁₉BrClN

Color and Shape: Solid

Molecular weight: 352.7

Ref: TM-T68680